SKStefan Klöppel

Stefan Klöppel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stefan Klöppel has a total of 271 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and Feasibility of the Bern Brain Training App for Older Adults With Subjective Cognitive Decline and Mild Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial

    by Anna-Katharine Brem, Esther Brill, Michael Falkner, Alexa Holfelder, Christine Krebs, Stefan Klöppel

    Background: Computerized cognitive training (CCT) aims to mitigate cognitive decline in subjective cognitive decline (SCD) and mild cognitive impairment (MCI). However, adherence and long-term engagement remain challenging in remote CCT interventions. Objective: Describe the development and design of the Bern Brain Training (BBT), a tablet-based app to remotely train cognitive functions and assess its feasibility, usability, and acceptability. This is a secondary analysis of a previously published randomized controlled trial (RCT). Methods: Unity Game Engine and C# programming were used to design 16 games targeting episodic, semantic, and working memory, and spatial abilities. We assessed feasibility, usability, and acceptability of the BBT (50 sessions in 10 weeks, each 24 minutes) in 116 participants with subjective cognitive decline (SCD, n=89) or mild cognitive impairment (MCI, n=27). One session per week was played in-clinic in a group setting of 4‐6 participants. Within the main RCT with parallel groups, participants were pseudo-randomized to one of three groups, with an allocation ratio of 1:1:1. The BBT was administered in all three treatment groups at different time points. Group 1 (n=36, 31%) started with the BBT (10 weeks); Group 2 (n=34, 29%) started with active control training (10 weeks), and then moved on to the BBT (10 weeks); Group 3 (n=46, 39%) started with the BBT (10 weeks) after a waiting period of 10 weeks. Results: Feasibility was high (adherence rate: mean 5.10, SD 0.69 BBT sessions/week; weekly group sessions: mean 9.18 SD 1.05; concluded BBT sessions: 5891, 91%). On a 7-point Likert scale, participants showed high motivation across cognitive domains and training groups (mean 6.15, SD 1.05), and groups did not differ significantly in adherence ( P>. 05). Usability was good with 61 (0.94%) help button presses recorded across 6489 sessions played. Acceptability (7-point Likert scale) was satisfying in game experience ratings of entertainment (mean 5.43, SD 1.39), with low frustration rates (mean 3.01, SD 1.79), despite the BBT being perceived as challenging (mean 5.52, SD 1.22). The games were perceived as most efficient in training memory (mean 5.7, SD 1.20) and thinking abilities (mean 5.43, SD 1.18). SCD and MCI did not differ significantly in game experience and perceived game efficacy ( P >.05). Conclusions: The BBT demonstrated high feasibility, usability, and acceptability. Its innovation lies in the participatory and professional game design, task diversity, adaptivity, and social elements, with a large sample size that sets it apart from other studies. These findings advance the field by demonstrating that tablet-based, remote cognitive training is feasible and well accepted in older adults with cognitive impairment, emphasizing the importance of these parameters for high training adherence and supporting its potential integration into clinical practice. Future research should extend evaluation to care-home settings and populations with more advanced cognitive impairment.

  • Open Access

    The More You Use It, the Less It Hurts: Real-World Effectiveness and Dose–Response of a Prescription Digital Back-Pain Therapeutic in 21,803 Patients (Preprint)

    by Gisbert W. Teepe, Stefan Klöppel, Nils Mühlenfeld, Markus Siegel

    BACKGROUND Digital therapeutics for back pain may improve access to structured exercise-based care, but large-scale real-world data on longitudinal outcomes, engagement effects, and non-completion patterns remain limited. ViViRA is a prescription digital therapeutic for non-specific back pain listed as a Digitale Gesundheitsanwendung (DiGA) in Germany. OBJECTIVE This post-marketing clinical follow-up (PMCF) study investigated pain trajectories, dose–response relationships, baseline predictors of clinically meaningful improvement, and patterns of programme non-completion METHODS We performed a retrospective analysis of de-identified real-world data from 21,803 patients who activated ViViRA between 2020 and 2025 and provided at least two pain ratings. Pain intensity was self-reported using the 11-point Numerical Rating Scale (NRS, 0–10). Longitudinal pain trajectories were examined using linear and quadratic mixed-effects models with individual random slopes, operationalised both by weeks since activation and by completed session number. Responders were defined as patients achieving an absolute pain reduction of ≥2 NRS points from onboarding to their best observed score within 90 days. Baseline predictors of clinically meaningful improvement were assessed using binary logistic regression models. RESULTS Pain followed a curvilinear trajectory in both analyses: initial improvement was followed by attenuation after approximately Week 8 or Session 20-34. Clear dose-response relationships were observed for both usage frequency and session adherence. Recommended users (≥ 3 sessions per week) achieved a predicted pain reduction of -1.32 NRS points (- 25.6%) at Week 12; non-users showed near-zero sustained improvement (-0.13 NRS, -2.5%). Patients with 75% session completion achieved -1.91 NRS (-35.2%) by Session 39, compared with -0.34 NRS (-6.3%) at 25% completion. Overall, 49.6% of patients with a baseline pain score ≥ 2 NRS met the MCID criterion. Results were consistent when a relative criterion (≥30% reduction) was applied (46.8%; κ = 0.843). The strongest independent predictors of response were higher initial pain score (OR = 1.33 per NRS point), acute pain duration, female sex, and absence of baseline pain medication and physiotherapy. Only 22.1% of patients completed all 39 sessions. However, more than one third of non-completers (36.6%) had already improved by ≥ 2 NRS points at their last report (18.6% reached a final pain score ≤ 2 NRS), suggesting that a meaningful share of apparent dropout reflects early success rather than disengagement. CONCLUSIONS In this large real-world PMCF cohort, ViViRA use was associated with engagement-dependent reductions in back pain, with the greatest improvements occurring during the early treatment phase and approximately half of patients achieving clinically meaningful pain relief. Higher use frequency and greater session completion were consistently associated with larger pain reductions. Although overall completion was low, non-completion did not uniformly indicate treatment failure, as a substantial subgroup of patients discontinued after achieving a clinically meaningful pain reduction. These findings highlight the importance of patient engagement, baseline symptom severity, and differentiated interpretation of dropout when evaluating digital therapeutics for non-specific back pain in routine care.

  • Open Access

    Implementation of Sensor-Augmented Conversational Agent for Personalized Lifestyle Support in Older Adults with Mild Cognitive Impairment: Two-Week Feasibility Study (Preprint)

    by Alexa Holfelder, Alexandre de Terrasson de Montleau, Rasita Vinay, Marcia Nißen, Stefan Klöppel, Tobias Kowatsch, Esther Brill

  • Open Access

    Sensor-Augmented Conversational Agent for Personalized Lifestyle Support in Older Adults with Mild Cognitive Impairment: Two-Week Feasibility Study (Preprint)

    by Alexa Holfelder, Alexandre de Terrasson de Montleau, Rasita Vinay, Marcia Nißen, Stefan Klöppel, Tobias Kowatsch, Esther Brill

    BACKGROUND Early lifestyle interventions may reduce dementia-related cognitive decline, but individuals with cognitive impairment often face barriers to accessing and maintaining such interventions. Smartphone applications and wearables may offer low-burden, real-time support. OBJECTIVE This study examined the feasibility and acceptability of a two-week sensor-augmented just-in-time adaptive intervention (JITAI) delivered via smartphone-based conversational agents (CAs) and a wearable fitness tracker in older adults with mild cognitive impairment (MCI). METHODS In this single-arm, feasibility study, 24 MCI participants (mean age: 75.9 years) used the intervention with a rule-based CA delivering two daily JITAI interventions: (1) a sensor-informed primary physical-activity component, in which continuously collected step-count data from a wrist-worn fitness tracker (Garmin Vivoactive 6) were used to assess vulnerability against a personalized step goal and deliver tailored walking prompts; and (2) an ecological momentary assessment-based secondary health-promoting component targeting one of six additional health domains (hydration, nutrition, cognitive exercise, sleep, social engagement, movement), assessed via momentary self-report. Both components followed the same JITAI decision logic: vulnerability assessment in the afternoon, receptivity evaluation if vulnerable, tailored prompt delivery if receptive, and adherence assessment at an evening check-in. Post-intervention questionnaires assessed technology acceptance, usability, working alliances and qualitative feedback. RESULTS Across the study period, engagement with the CA was high for both components. Afternoon response rates were 86.6% for the primary physical-activity component and 84.2% for the secondary health-promoting-activities component. Evening check-in response rates were 85.6% and 79.3%. Among all responses classified as vulnerable (38.7% and 32.1% of afternoon interactions on the physical-activity and secondary-activity components, respectively), 85.4% and 75.9% were receptive, of which 76.6% and 70.7% resulted in adherence at the evening check-in. On days satisfying the full JITAI chain for physical activity, participants exceeded their personalized step goal, reaching a mean of 170% of goal (SD ± 95) and a mean evening step count of 7,718 steps (SD ± 3,453). The wearable-based data acquisition pipeline was feasible and largely reliable under study conditions, with the Garmin device supplying step-count data in 80.8% of decision points, the smartphone in 17.4%, and manual self-report required in only 1.8% of cases. Participants rated the CA favorably across all technology acceptance and usability domains, with all mean scores above the neutral midpoint on seven-point Likert scales. Qualitative analysis described an intervention experienced as accessible and structuring. CONCLUSIONS This pilot study supports the short-term feasibility and acceptability of integrating wearable-derived step data into a smartphone-based CA-delivered JITAI for older adults with MCI. Passive sensing may support personalized intervention delivery while reducing reliance on self-report. However, as a feasibility study, it was not designed to provide evidence of efficacy. Controlled studies with adaptive decision times, sensor-derived baselines, and more diverse samples are needed to evaluate efficacy and sustained behavioral benefits. CLINICALTRIAL NA

  • Open Access

    Video-Supported Remote Cognitive Assessment in General Practice—A Pilot Mixed-Method Study on Usability, Acceptability and Feasibility

    by Alexa Holfelder, Esther Brill, Rachid Guerchouche, Minh Tran-Duc, Jacob Lahr, Stefan Klöppel

    Background/Objectives: Access to specialists and diagnostic resources continues to limit differential diagnosis of cognitive impairment in primary care. This pilot study examined the feasibility, usability, and clinical integration of a digitally supported Remote Cognitive Assessment (RCA) model embedded in general practice settings. Methods: A mixed-method design was used, combining structured quantitative surveys from patients (n = 10; mean age = 77.03; SD = 14.1) and neuropsychologists (10 RCAs completed by three neuropsychologists) with qualitative interviews from general practitioners (GP; n = 4). Patients were assessed remotely via a secure videoconference system operated by trained neuropsychologists. Assessments were conducted in the GP’s office, supported by local staff, to facilitate the process. Results: Patients reported high satisfaction with audio (M = 8; SD = 2.28) and video quality (M = 9.17; SD = 1.17) and expressed a strong willingness to recommend RCA (M = 8.83; SD = 1.17) on a 10-point Likert scale. Despite moderate scores for perceived simplicity (M = 5; SD = 3.41) and effectiveness (M = 5.83; SD = 2.14), overall acceptance (M = 8.33; SD = 0.82) was favorable, especially given the older age of participants. Neuropsychologists rated technical functionality positively (audio quality M = 8.17; SD = 1.18; video quality M = 8; SD = 1.67) but raised concerns about clinical utility and diagnostic depth (effectiveness M = 2.83; SD = 2.71). GPs highlighted the benefits of local facilitation, early screening, and improved access to specialist input while also noting space limitations, communication gaps, and the need for sustainable infrastructure. Conclusions: The RCA model was well accepted by patients and GPs, and technically feasible for neuropsychologists. However, neuropsychologists reported important reservations regarding usability and effectiveness. The results suggest an important mismatch between patient satisfaction and clinical confidence and RCA cannot yet be recommended for routine clinical implementations based on patient acceptability alone. This model holds promises for hybrid cognitive care, particularly in underserved or rural areas, but future development must prioritize diagnostic confidence and clinician workflow usability before scalable integration into rural cognitive care pathways can be established.

  • Open Access

    Therapeutic Drug Monitoring of Psychotropic Drugs in Inpatient Psychiatry: Local Practice and Improvement

    by Philippe Pfeifer, Beat Mathys, Emre Mustafa Alan, Tobias Bracht, Susanne Choinowski, Kristina Adorjan, Stefan Klöppel

    Therapeutic drug monitoring (TDM) is an important tool to personalize psychopharmacotherapy, thereby optimizing its effectiveness and tolerability. Despite consensus on medications, indications, and implementation of TDM, reports indicate a substantial gap between theory and practice. To further investigate this gap, the current application of TDM was assessed in the adult inpatient settings of the University Hospital of Psychiatry and Psychotherapy of Bern, Switzerland. To assess current practice in TDM, drug level measurements were analyzed in 2022. In parallel, an online survey as well as standardized interviews were conducted with the clinic's physicians. To improve TDM applications, a handout was designed with the core items of the TDM guidelines, revised the orders for TDM in the hospital information system, and held an internal lecture on TDM. In clinical practice, TDM was primarily used for clozapine, lithium, and valproate. Other drugs appear to be underrepresented. Although physicians generally rated their knowledge of TDM as good, they identified the need for improvement in medical knowledge. The main source of error in TDM was the incorrect timing of blood samples. There was disagreement among the physicians about the number of TDMs. Therapeutic drug monitoring is well established for clozapine, lithium, and valproate. Compared to the international consensus, physicians applied TDM to a narrower spectrum of psychotropic drugs. Efforts are needed to improve TDM. To optimize TDM, a handout was created, and the TDM request was adapted in the hospital according to guidelines recommendations based on findings of TDM requests, the survey, and interviews.


  • Open Access

    Ethics of Sensor-Based Surveillance of People with Dementia in Clinical Practice

    by Jacob Lahr, Nicole Schulze, Larissa N. Wüst, Claus Beisbart, Lena C. Bruhin, Marcello Ienca, Tobias Nef, Manuel Trachsel, Stefan Klöppel

    Sensor-based surveillance technology (SST) is increasingly employed in the care of people with dementia (PwD) in hospitals, nursing homes, and home care. With improved functionality and availability of SST, there will likely be a growing utilization in clinical settings. In the context of staff shortage, the expected resource-efficient safety benefits are attractive but must be critically balanced against concerns that basic ethical principles are violated. In this discussion paper, we provide a brief overview of frequently used SST and discuss ethical issues associated with their use. We identify intrusion into privacy and the complex interaction between stakeholders as the biggest challenges. Moreover, the frequent lack of decision-making capacity in PwD poses particular ethical challenges. Evidence concerning safety benefits exists mostly for the detection of patients leaving the intended area (i.e., getting up, leaving the premises) or occurring falls. The level of privacy intrusion to detect occurring falls varies widely between different sensor systems. Finally, we propose best practice recommendations for the clinical implementation of SST in the care of PwD, and we address the circumstances under which the use of sensors can be ethically justified despite the absence of legally valid informed consent.


  • Open Access

    Perceptions of Ad Hoc Entrustment, the Need for Supervision, and Coping Strategies in Clinical Residents: A Qualitative Study

    by Seraina Petra Msc Lerch, Sören MD Huwendiek, Mathieu Md Nendaz, Stefan Klöppel, Severin Md Pinilla

    Purpose: Negotiating the balance between clinical residents’ roles as health care practitioners and learners is a struggle in postgraduate medical education. Although ad hoc entrustment has been studied in this context, little is known about residents’ perceptions of ad hoc over- and underentrustment, the need for supervision, and their coping strategies. Therefore, this study explored residents’ perspectives concerning these topics. Method: The authors conducted semistructured, in-depth interviews with 12 purposively sampled residents in the graduate medical educational phase of residency who were involved in geriatric psychiatry rotations from different training sites and settings in Switzerland. The interviews were conducted between January and March 2022. Researchers used a thematic analysis to explore and interpret the data within a constructivist research paradigm. Results: Four overarching themes were identified: ad hoc and default entrustment in the workplace, perceptions of supervision, applied coping strategies to over- and underentrustment, and suggestions for improvement. Residents described entrustment decisions in the workplace as a default, often covert process and as an explicit, ad hoc delegation of clinical tasks. Perceived optimal supervision entailed sufficient time, frequency, and availability of the supervision, supervisors referring to scientific evidence in their reasoning, trustworthiness, and a psychologically safe learning environment. Residents described suboptimal supervision as lacking appropriate feedback timing, having little or nonexistent time in general, using an ambivalent communication style, and clinical decision-making by the supervisor that is not explicit. Residents applied instrumental, appraisal-focused, and emotion-focused coping strategies. Their suggestions for improvement included instructional design of the workplace-based curriculum, supervision, teaching content, and contextual factors. Conclusions: Within postgraduate training, addressing the organizational and contextual factors of entrustment and resident supervision is essential. Default entrustment decisions need to be explored and explicitly addressed to prevent overentrustment, meet residents’ need for supervision, and effectively coach residents to maintain their well-being.